Clinical Trial Update: Tranexamic Acid in Dacryocystorhinostomy [NA]

View source ↗

Summary

Clinical trial update indicates tranexamic acid is being studied in dacryocystorhinostomy for nasolacrimal duct obstruction; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasolacrimal Duct Obstruction

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Nasolacrimal Tract Obstruction | NA | Status: UNKNOWN